Literature DB >> 2833613

Efficient expression in insect cells of a soluble, active human insulin receptor protein-tyrosine kinase domain by use of a baculovirus vector.

L Ellis1, A Levitan, M H Cobb, P Ramos.   

Abstract

The human insulin receptor (IR) is a transmembrane glycoprotein, whose cytoplasmic domain contains an insulin-activated protein-tyrosine kinase (EC 2.7.1.112). By the use of an appropriately engineered baculovirus expression vector, a soluble cytoplasmic derivative of this domain was expressed in the insect cell line Spodoptera frugiperda (Sf9). At 24 to 48 h after Sf9 cells were infected with recombinant virus, a protein of the size expected for this domain (approximately 48 kilodaltons) constituted a major band when total cell lysates of metabolically labeled cells were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and fluorography. This protein (designated AchIRPTK) was immunoprecipitated by three monoclonal antibodies, each of which recognizes a distinct antigenic site of the IR cytoplasmic domain and requires the native structure of the protein for recognition and one of which binds at or near the physiologically relevant site(s) of IR autophosphorylation. In vivo, AchIRPTK was phosphorylated on both tyrosine and serine residues. When affinity purified, the kinase was active in vitro; it autophosphorylated exclusively on tyrosine residues, and phosphorylated the exogenous substrates histone H2b and poly(Glu-Tyr). The expression of an active IR protein-tyrosine kinase molecule in this heterologous cell system provides an efficient experimental method for producing this domain in quantity for enzymatic and structural studies.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2833613      PMCID: PMC253191          DOI: 10.1128/JVI.62.5.1634-1639.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling.

Authors:  Y Ebina; L Ellis; K Jarnagin; M Edery; L Graf; E Clauser; J H Ou; F Masiarz; Y W Kan; I D Goldfine
Journal:  Cell       Date:  1985-04       Impact factor: 41.582

2.  Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  1984-01-25       Impact factor: 16.971

3.  Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.

Authors:  C Yanisch-Perron; J Vieira; J Messing
Journal:  Gene       Date:  1985       Impact factor: 3.688

4.  Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes.

Authors:  A Ullrich; J R Bell; E Y Chen; R Herrera; L M Petruzzelli; T J Dull; A Gray; L Coussens; Y C Liao; M Tsubokawa
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

Review 5.  The molecular mechanism of insulin action.

Authors:  C R Kahn
Journal:  Annu Rev Med       Date:  1985       Impact factor: 13.739

6.  A membrane-anchored cytoplasmic domain of the human insulin receptor mediates a constitutively elevated insulin-independent uptake of 2-deoxyglucose.

Authors:  L Ellis; D O Morgan; E Clauser; R A Roth; W J Rutter
Journal:  Mol Endocrinol       Date:  1987-01

7.  Modification and secretion of human interleukin 2 produced in insect cells by a baculovirus expression vector.

Authors:  G E Smith; G Ju; B L Ericson; J Moschera; H W Lahm; R Chizzonite; M D Summers
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Production of human beta interferon in insect cells infected with a baculovirus expression vector.

Authors:  G E Smith; M D Summers; M J Fraser
Journal:  Mol Cell Biol       Date:  1983-12       Impact factor: 4.272

10.  Insulin action is blocked by a monoclonal antibody that inhibits the insulin receptor kinase.

Authors:  D O Morgan; L Ho; L J Korn; R A Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

View more
  8 in total

1.  Inhibition of insulin receptor phosphorylation by peptides derived from major histocompatibility complex class I antigens.

Authors:  T Hansen; J Stagsted; L Pedersen; R A Roth; A Goldstein; L Olsson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

2.  Secretion of the extracellular domain of the human insulin receptor from insect cells by use of a baculovirus vector.

Authors:  J Sissom; L Ellis
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

3.  Another version of the human insulin receptor kinase domain: expression, purification, and characterization.

Authors:  M Villalba; S R Wente; D S Russell; J C Ahn; C F Reichelderfer; O M Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

4.  Identification of the glycogenic compound 5-iodotubercidin as a general protein kinase inhibitor.

Authors:  D Massillon; W Stalmans; G van de Werve; M Bollen
Journal:  Biochem J       Date:  1994-04-01       Impact factor: 3.857

5.  Differential regulation of multiple hepatic protein tyrosine phosphatases in alloxan diabetic rats.

Authors:  J M Boylan; D L Brautigan; J Madden; T Raven; L Ellis; P A Gruppuso
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

6.  Sulphydryl agents modulate insulin- and epidermal growth factor (EGF)-receptor kinase via reaction with intracellular receptor domains: differential effects on basal versus activated receptors.

Authors:  S Clark; N Konstantopoulos
Journal:  Biochem J       Date:  1993-05-15       Impact factor: 3.857

7.  Epidermal growth factor binding induces a conformational change in the external domain of its receptor.

Authors:  C Greenfield; I Hiles; M D Waterfield; M Federwisch; A Wollmer; T L Blundell; N McDonald
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

8.  Tyrosine phosphorylation of Munc18c on residue 521 abrogates binding to Syntaxin 4.

Authors:  Veronica Aran; Nia J Bryant; Gwyn W Gould
Journal:  BMC Biochem       Date:  2011-05-06       Impact factor: 4.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.